The anti-Trop-2 antibody-drug conjugate Sacituzumab Govitecan-effectiveness, pitfalls and promises.

Ann Transl Med

Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), University "G. D'Annunzio", Chieti, Italy.

Published: May 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347060PMC
http://dx.doi.org/10.21037/atm-22-621DOI Listing

Publication Analysis

Top Keywords

anti-trop-2 antibody-drug
4
antibody-drug conjugate
4
conjugate sacituzumab
4
sacituzumab govitecan-effectiveness
4
govitecan-effectiveness pitfalls
4
pitfalls promises
4
anti-trop-2
1
conjugate
1
sacituzumab
1
govitecan-effectiveness
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!